Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US9314538B2 · kind B2 · utility
8Cited by
14References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 13, 2015 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Jul 13, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.